Capital Impact Advisors, LLC Invitae Corp Transaction History

Capital Impact Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 23, 2023	BUY	$1.2 - $2.73 $59,097 - $134,447	49,248 Added 49.37%	149,007 $201,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $90,621 - $191,311	52,995 Added 113.32%	99,759 $185,000
Q3 2022 Nov 21, 2022	SELL	$1.9 - $8.63 $59,006 - $268,013	-31,056 Reduced 39.91%	46,764 $140,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $6,877 - $29,093	3,229 Added 4.33%	77,820 $190,000
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $468,431 - $1.16 Million	74,591 New	74,591 $594,000

Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $338,291 - $659,782	-23,013 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $559,446 - $773,236	-23,013 Reduced 50.0%	23,013 $654,000
Q2 2021 Aug 17, 2021	SELL	$26.09 - $40.4 $327,142 - $506,575	-12,539 Reduced 21.41%	46,026 $1.55 Million
Q1 2021 May 18, 2021	SELL	$33.06 - $56.93 $7.16 Million - $12.3 Million	-216,435 Reduced 78.7%	58,565 $2.24 Million
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $2.93 Million - $4.31 Million	75,000 Added 37.5%	275,000 $11.5 Million
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $5.69 Million - $8.93 Million	200,000 New	200,000 $8.67 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.